Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development

Aspergillosis is a common fungal infection with systemic characteristics, which is caused by various species of Aspergillus. The infection could develop in immunocompromised and immunocompetent patients under specific circumstances. Based on the clinical features and type of invasion, aspergillosis...

Full description

Bibliographic Details
Main Author:	Ali AL-Janabi
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2020-03-01
Series:	Reviews in Clinical Medicine
Subjects:	aspergilloma aspergillosis rheumatoid arthritis tnf inhibitors
Online Access:	https://rcm.mums.ac.ir/article_15121_2838ee381264db9cf0abaa51852a3c8a.pdf

Similar Items

Pediatric Pulmonary and Thoracic Aspergillosis
by: Preeyacha Pacharn, et al.
Published: (2020-07-01)

Role of itraconazole in the management of aspergillosis in treated patients of pulmonary tuberculosis
by: Gupta P, et al.
Published: (2005-01-01)

A 10-year study reveals clinical and laboratory evidence for the ‘semi-invasive’ properties of chronic pulmonary aspergillosis
by: Jasper Fuk-Woo Chan, et al.
Published: (2016-01-01)

Prevalence of Vitamin D Deficiency in Treatment-Naïve Subjects with Chronic Pulmonary Aspergillosis
by: Inderpaul Singh Sehgal, et al.
Published: (2020-10-01)

Clinico-mycological profile of suspected pulmonary aspergillosis cases
by: Bavleen Kaur, et al.
Published: (2023-01-01)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
by: Nitin Gupta, et al.
Published: (2020-08-01)

Case report: retroperitoneal aspergilloma in a patient with rheumatoid arthritis presenting as malignant tumor
by: Risa Shinoki, et al.
Published: (2018-07-01)

The metabolic effects of TNF inhibitors in rheumatoid arthritis patients
by: Alexandra Jitaru, et al.
Published: (2019-12-01)

Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
by: Josef S. Smolen, et al.
Published: (2020-08-01)

Cauda equina aspergilloma in an immunocompetent individual: A case report
by: Amresh S Bhaganagare, et al.
Published: (2013-01-01)

Endobronchial amphotericin B to treat hemoptysis in an inoperable patient with aspergillosis
by: Mário Pinto, et al.
Published: (2024-03-01)

Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients
by: Chamaida Plasencia-Rodríguez, et al.
Published: (2024-09-01)

Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive
by: Leslie R. Harrold, et al.
Published: (2024-01-01)

The first biological choice in patients with rheumatoid arthritis: data from the Moroccan register of biotherapies
by: Meryem Eddaoudi, et al.
Published: (2021-02-01)

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
by: Iannone F, et al.
Published: (2022-06-01)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
by: Gemma E. Hayes, et al.
Published: (2016-06-01)

Treatment in Patients with Psoriatic Disease and Rheumatoid Arthritis: Seven Case Reports
by: Tomoko Akeda, et al.
Published: (2023-01-01)

Effects of Different Treatment Methods Used in Patients with Rheumatoid Arthritis on the Trabecular and Cortical Structure of the Mandible
by: Hatice Yemenoglu, et al.
Published: (2025-01-01)

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
by: Yen-Ju Lin, et al.
Published: (2020-04-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
by: Olivera Boskovic, et al.
Published: (2020-01-01)

Risk of Active Tuberculosis During Anti-TNF-α Inhibitor Use to Treat Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials
by: Hanxin Wu, et al.
Published: (2024-09-01)

Study on Tumor Necrosis Factor-α· Gene Polymorphism in Rheumatoid Arthritis
by: Kim Kyung-Un, et al.
Published: (2007-06-01)

Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity
by: Mones M. Abu Shady, et al.
Published: (2015-07-01)

Proinflammatory cytokines profile in patients with Rheumatoid arthritis
by: Shahlaa M. Saleh, et al.
Published: (2009-04-01)

Plasma Sclerostin Levels in Rheumatoid Arthritis Women on TNF-α Inhibitor Therapy
by: Anna Szeremeta, et al.
Published: (2024-05-01)

Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis
by: Antonio Julià, et al.
Published: (2022-06-01)

CT-guided microwave ablation of the nonsurgical aspergilloma
by: Adam Devine, et al.
Published: (2023-01-01)

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients
by: Kim HJ, et al.
Published: (2020-03-01)

Relapse rates after elective discontinuation of anti-TNF therapy in rheumatoid arthritis: a meta-analysis and review of literature
by: Arduino A. Mangoni, et al.
Published: (2019-03-01)

Chronic Pulmonary Aspergillosis: Literature Review and Demonstration of Own Observations
by: N. G. Nikolaeva, et al.
Published: (2021-11-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
by: Alexander Vugler, et al.
Published: (2022-11-01)

TUMOR NECROSIS FACTOR-α MEMBRANE-BOUND AND SOLUBLE RECEPTORS IN NORM AND IN RHEUMATOID ARTHRITIS
by: A. A. Alshevskaya, et al.
Published: (2012-05-01)

Comparison of therapeutic effects of different mesenchymal stem cells on rheumatoid arthritis in mice
by: Qing Zhang, et al.
Published: (2019-06-01)

Primary aspergilloma and subacute invasive aspergillosis in two AIDS patients Aspergiloma primário e aspergilose invasiva subaguda em dois pacientes com AIDS
by: Roberto Martinez, et al.
Published: (2009-02-01)

Corrigendum: An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
by: Alexander Vugler, et al.
Published: (2024-10-01)

Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis
by: Kelly L. Hamilton, et al.
Published: (2022-12-01)

Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
by: Emine Duran, et al.
Published: (2023-06-01)

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE
by: Roy Fleischmann, et al.
Published: (2024-03-01)

Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis
by: Alexander A. Stepanov, et al.
Published: (2023-02-01)